1-6 of 6
Fulvio Massaro
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes of Patients with Hodgkin Lymphoma Receiving Brentuximab Vedotin (BV) As Maintenance Therapy after ASCT According to Previous Exposure to BV. a Retrospective Analysis of the EBMT Lymphoma Working Party in Collaboration with Geltamo, FIL, Lysarc, and Turkish Lymphoma Group

Maria Carmen Martinez Munoz, Irma Khvedelidze, Mathilde Fekom, Benedicte Deau Fischer, Amira Marouf, Herve Ghesquieres, Luc-Matthieu Fornecker, Francesco Merli, Piero Maria Stefani, Fulvio Massaro, Barbara Botto, A. Burhan Ferhanoglu, Olga Meltem Akay, Murat Ozbalak, Manuel Espeso De Haro, Samuel Romero, Jaques-Emmanuel Galimard, Bertram Glass, Ali Bazarbachi, Anna Sureda Balari
Journal: Blood
Blood (2024) 144 (Supplement 1): 1663.
https://doi.org/10.1182/blood-2024-205007
Published: 2024
Journal Articles

A Retrospective Analysis of Brentuximab Vedotin and Pembrolizumab Combination As Salvage Treatment for Patients with Relapsed or Refractory Hodgkin Lymphoma

Fulvio Massaro, MD, Nathalie Meuleman, PhD MD, Dominique Bron, MDPhD, Marie Maerevoet, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-137399
Published: 2020
Journal Articles

Five Years after Frontline Tyrosine-Kinase Inhibitor (TKI) Treatment Initiation for Chronic Myeloid Leukemia: What Does It Happen in a Real-Life Setting?

Daniela De Benedittis, MD, Massimo Breccia, MD, Ida Carmosino, Elena Mariggiò, MD, Matteo Molica, MD, Sara Mohamed, MD, Fulvio Massaro, MD, Maria Lucia De Luca, MD, Emilia Scalzulli, MD, Chiara Lisi, MD, Mauro Passucci, MD, Gioia Colafigli, MD, Maria Giovanna Loglisci, MD, Daniela Diverio, Marco Mancini, Robin Foà, MD, Roberto Latagliata
Journal: Blood
Blood (2018) 132 (Supplement 1): 1746.
https://doi.org/10.1182/blood-2018-99-117272
Published: 2018
Journal Articles

Does Bone Marrow Fibrosis Play a Role in the Prognostication of Newly Diagnosed Polycythemia Vera Patients?

Matteo Molica, MD, Daniela De Benedictis, MD, Emilia Scalzulli, MD, Ida Carmosino, Laura Cesini, Marta Chisini, MD, Maria Lucia De Luca, MD, Fulvio Massaro, MD, Gioia Colafigli, MD, Marco Mancini, Stefania Trasarti, MD, Massimo Breccia, MD PhD, Robin Foa, MD, Roberto Latagliata
Journal: Blood
Blood (2017) 130 (Supplement 1): 4184.
https://doi.org/10.1182/blood.V130.Suppl_1.4184.4184
Published: 2017
Journal Articles

Impact of Comorbidities and Body Mass Index in Myelofibrosis Patients Treated with Ruxolitinib: A Retrospective Analysis

Massimo Breccia, MD, Mario Tiribelli, MD, Massimiliano Bonifacio, Alessia Tieghi, MD, Nicola Polverelli, Micaela Bergamaschi, MD, Francesco Cavazzini, MD, Giuseppe Cimino, MD, Mariella D'Adda, MD, Monica Crugnola, MD, Costanza Bosi, MD, Marco Spinsanti, PhD, Matteo Molica, Angelo Fama, MD, Alessandro Andriani, MD, Elisa Cerqui, MD, Antonio Lazzaro, Luigi Scaffidi, Fulvio Massaro, Roberto Latagliata, MD, Francesca Celesti, MD, Roberto massimo Lemoli, Renato Fanin, MD, Domenico Russo, MD, Franco Aversa, MD, Antonio Cuneo, MD, Michele Cavo, MD, Nicola Vianelli, MD, Giuliana Alimena, MD, Francesca Palandri, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5464.
https://doi.org/10.1182/blood.V128.22.5464.5464
Published: 2016
Journal Articles

Incidence of Severe (≤ 10g/dl) Chronic Anemia in Elderly Patients with Newly Diagnosed Chronic Myeloid Leukemia Treated with Imatinib and Role of Erythropoietin Therapy

Laura Cesini, MD, Ida Carmosino, Melissa Campanelli, MD, Massimo Breccia, MD, Maria Lucia De Luca, Gioia Colafigli, Matteo Molica, Fulvio Massaro, Federico Vozella, Daniela Diverio, PhD, Marco Mancini, MD, Giuliana Alimena, Roberto Latagliata, MD
Journal: Blood
Blood (2016) 128 (22): 1903.
https://doi.org/10.1182/blood.V128.22.1903.1903
Published: 2016